The University of Chicago Header Logo

Connection

Hilary Kenny to Bevacizumab

Back to Details
This is a "connection" page, showing publications Hilary Kenny has written about Bevacizumab.
Hilary Kenny
Connection Strength
0.155
Bevacizumab
  1. Cancer-derived small extracellular vesicles promote angiogenesis by heparin-bound, bevacizumab-insensitive VEGF, independent of vesicle uptake. Commun Biol. 2019; 2:386.
    View in: PubMed
    Score: 0.155
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.